Joint (JYNT) Competitors $11.19 +0.19 (+1.73%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends JYNT vs. ORC, ABL, ALTI, TINV, CTO, GAMI, FPI, PBT, CHCT, and GMREShould you be buying Joint stock or one of its competitors? The main competitors of Joint include Orchid Island Capital (ORC), Abacus Life (ABL), AlTi Global (ALTI), Tiga Acquisition (TINV), CTO Realty Growth (CTO), GAMCO Investors (GAMI), Farmland Partners (FPI), Permian Basin Royalty Trust (PBT), Community Healthcare Trust (CHCT), and Global Medical REIT (GMRE). These companies are all part of the "trading" industry. Joint vs. Orchid Island Capital Abacus Life AlTi Global Tiga Acquisition CTO Realty Growth GAMCO Investors Farmland Partners Permian Basin Royalty Trust Community Healthcare Trust Global Medical REIT Orchid Island Capital (NYSE:ORC) and Joint (NASDAQ:JYNT) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, analyst recommendations, profitability, risk, valuation, community ranking and earnings. Does the media favor ORC or JYNT? In the previous week, Orchid Island Capital had 1 more articles in the media than Joint. MarketBeat recorded 5 mentions for Orchid Island Capital and 4 mentions for Joint. Joint's average media sentiment score of 0.42 beat Orchid Island Capital's score of 0.35 indicating that Joint is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Orchid Island Capital 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Joint 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Does the MarketBeat Community prefer ORC or JYNT? Orchid Island Capital received 12 more outperform votes than Joint when rated by MarketBeat users. However, 62.53% of users gave Joint an outperform vote while only 61.12% of users gave Orchid Island Capital an outperform vote. CompanyUnderperformOutperformOrchid Island CapitalOutperform Votes29461.12% Underperform Votes18738.88% JointOutperform Votes28262.53% Underperform Votes16937.47% Which has preferable earnings & valuation, ORC or JYNT? Joint has higher revenue and earnings than Orchid Island Capital. Joint is trading at a lower price-to-earnings ratio than Orchid Island Capital, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrchid Island Capital$75.70M8.45-$39.23M$1.057.63Joint$117.70M1.42-$9.75M-$1.14-9.82 Is ORC or JYNT more profitable? Orchid Island Capital has a net margin of 0.00% compared to Joint's net margin of -13.95%. Joint's return on equity of 8.24% beat Orchid Island Capital's return on equity.Company Net Margins Return on Equity Return on Assets Orchid Island CapitalN/A -4.08% -0.46% Joint -13.95%8.24%2.33% Which has more risk and volatility, ORC or JYNT? Orchid Island Capital has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500. Comparatively, Joint has a beta of 1.6, suggesting that its stock price is 60% more volatile than the S&P 500. Do insiders & institutionals have more ownership in ORC or JYNT? 32.7% of Orchid Island Capital shares are held by institutional investors. Comparatively, 76.9% of Joint shares are held by institutional investors. 0.6% of Orchid Island Capital shares are held by company insiders. Comparatively, 30.2% of Joint shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts recommend ORC or JYNT? Orchid Island Capital currently has a consensus price target of $9.50, suggesting a potential upside of 18.53%. Joint has a consensus price target of $17.50, suggesting a potential upside of 56.39%. Given Joint's stronger consensus rating and higher probable upside, analysts plainly believe Joint is more favorable than Orchid Island Capital.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Orchid Island Capital 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Joint 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryJoint beats Orchid Island Capital on 11 of the 18 factors compared between the two stocks. Get Joint News Delivered to You Automatically Sign up to receive the latest news and ratings for JYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JYNT vs. The Competition Export to ExcelMetricJointPatent owners & lessors IndustryMedical SectorNASDAQ ExchangeMarket Cap$167.63M$1.03B$5.21B$9.15BDividend YieldN/A6.95%5.13%4.03%P/E Ratio-9.825.6688.0817.36Price / Sales1.42300.521,243.2778.03Price / Cash13.8211.9443.7535.97Price / Book6.663.365.314.79Net Income-$9.75M-$2.81M$122.62M$225.00M7 Day Performance8.33%4.38%0.61%2.62%1 Month Performance8.96%8.99%2.56%3.81%1 Year Performance23.78%5.22%25.79%20.10% Joint Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JYNTJoint3.6618 of 5 stars$11.19+1.7%$17.50+56.4%+23.8%$167.67M$120.80M-9.82320Positive NewsORCOrchid Island Capital3.4843 of 5 stars$7.55-2.6%$9.50+25.8%-5.4%$602.87M$75.70M7.192,018ABLAbacus Life3.9145 of 5 stars$6.92flat$14.30+106.6%-37.9%$585.98M$102.41M-38.4482Gap DownALTIAlTi Global1.4513 of 5 stars$4.14+2.5%$9.00+117.4%-34.9%$578.88M$246.97M-2.37490Short Interest ↑TINVTiga AcquisitionN/A$16.74-3.3%N/A+97.3%$577.53MN/A0.00N/AHigh Trading VolumeCTOCTO Realty Growth2.4343 of 5 stars$19.24+0.6%$21.00+9.1%+18.1%$576.74M$118.66M32.6130GAMIGAMCO InvestorsN/A$22.80-2.1%N/A+24.4%$553.11M$235.87M8.77170Gap DownFPIFarmland Partners0.8453 of 5 stars$11.38-0.3%N/A+2.4%$548.21M$58.34M40.6430PBTPermian Basin Royalty Trust0.4071 of 5 stars$11.71+0.3%N/A-19.9%$545.80M$37.74M15.01N/ACHCTCommunity Healthcare Trust1.475 of 5 stars$18.71-0.2%$21.25+13.6%-25.8%$528.41M$115.61M-207.8937GMREGlobal Medical REIT4.5772 of 5 stars$7.63+1.5%$11.25+47.4%-22.5%$509.71M$136.39M-381.3130Short Interest ↑ Related Companies and Tools Related Companies Orchid Island Capital Competitors Abacus Life Competitors AlTi Global Competitors Tiga Acquisition Competitors CTO Realty Growth Competitors GAMCO Investors Competitors Farmland Partners Competitors Permian Basin Royalty Trust Competitors Community Healthcare Trust Competitors Global Medical REIT Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:JYNT) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Joint Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Joint With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JYNT Stock Alerts